Sermorelin: Benefits, Mechanism, and What the Research Shows (2026) Most pages on sermorelin benefits describe an “anti-aging” wonder drug, but the published record is narrower and older than the marketing suggests. Sermorelin is a fragment of a natural hormone that was once an FDA-approved pediatric diagnostic, and the human data on it comes mostly from … Read more
Semax: Benefits, Nootropic Mechanism, and Research Status (2026) Most write-ups on semax benefits borrow their claims from vendor pages, not from the underlying studies. The real evidence is narrower and more specific: semax is a Russian-developed heptapeptide studied mainly for stroke recovery and cognition, and most of its mechanism data comes from rats, not people. … Read more
20 Units of Semaglutide Is How Many mg? The Unit Math Explained (2026) 20 units of semaglutide is how many mg? There is no single answer for every vial, because a “unit” here is not a fixed amount of drug. It is a volume mark borrowed from insulin syringes, and the milligram total depends on … Read more
Semaglutide: How It Works, Results, and Side Effects (2026) Semaglutide benefits are unusual in the peptide world, because most of them come from large placebo-controlled human trials rather than animal work or marketing claims. Semaglutide is a modified version of a natural gut hormone, and it is one of the few peptides that has moved … Read more
Selank: Benefits, Anxiolytic Mechanism, and Research Status (2026) Most claims about Selank benefits come from a small, mostly Russian body of research, not from large Western trials. Selank is a synthetic heptapeptide built from tuftsin, a natural immune-signaling fragment, and it has been studied mainly as an anxiolytic (anti-anxiety) and nootropic compound. The honest summary … Read more
Retatrutide Benefits: What the Clinical Research Actually Shows (2026) Retatrutide (Eli Lilly, LY3437943) is an investigational once-weekly triple agonist of the GIP, GLP-1, and glucagon receptors. Most summaries of retatrutide benefits lead with one headline number (roughly 24 percent body weight lost) and stop there. The fuller research picture is more useful: retatrutide is a … Read more
Research Use Only Meaning: What “RUO” Actually Says About a Peptide (July 2026) The research use only meaning behind that small disclaimer on a peptide product page is narrower than most buyers assume. “Research use only” (RUO) is a labeling claim, not a legal status, and it does not answer the real question: is this … Read more
Peptides for Women: What the Research Shows, Goal by Goal (2026) Search interest in peptides for women usually collapses several very different goals into one word, and the science does not. The compounds women look up sit in separate categories: one is an FDA-approved sexual-desire drug, one is an approved weight-management medicine, one is a … Read more
Peptides for Weightloss: Which Ones Are Studied and How They Compare (2026) Search “peptides for weight loss” and the results blur two different worlds together: prescription GLP-1 medicines with landmark human trials, and research-use-only compounds with almost no human data at all. Separating those two groups is the job of this page. The Compound Universe … Read more
Peptides for Weight Loss in Women: What the Research Shows (2026) Most searches for peptides for weight loss for women return supplement ads, not evidence. The reality is narrower and better documented: the compounds with real human trial data are a small group of gut-hormone peptides (GLP-1 and dual GLP-1/GIP receptor agonists), and the trials … Read more